Clinical trial
A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in…
NCT00442793 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00442793 |
|---|---|
| Title | A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. |
| Official title | A Randomized, Open Label Study Comparing the Effect of Mircera and Epoetin Beta on Hemoglobin Response in Patients With Chronic Kidney Disease Who Are on Dialysis |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin beta, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 265 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Mar 2, 2007 |
| Last update posted | Nov 2, 2016 |
| Countries | China, Hong Kong |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: